Delivery Order SPE2DB20D2014-SPE2DB24FB02X

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $36,782.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 4, 2025 with a completion date of June 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $3,033.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 21, 2025, with a completion date of May 22, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $1,042.60 firm fixed price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract does not have a set-aside designation and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,543.03 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The $10,160.60 firm fixed price delivery order, issued under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, has a performance period through March 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is the sole awardee on...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $11,531.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $50,532.98 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 17, 2024. The contract was awarded without a...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $2,351.97 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,757.50 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 5, 2024. The firm fixed-price contract has an ultimate completion date of August 6, 2024 and is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,120.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 5, 2024, with a completion date of March 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB02X
    Delivery Order

This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $10,512.46 firm fixed price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a completion date of February 8, 2024 and was awarded on February 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.

Generated 5/8/24, 9:40 AM